Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors

Expert Opinion on Drug Delivery

Volumn 8, Issue 10, 2011, Pages 1323-1340

  Wadee, Ameena ^a   Pillay, Viness ^a   Choonara, Yahya E ^a   Du Toit, Lisa C ^a   Penny, Clement ^a   Ndesendo, Valence M K ^a   Kumar, Pradeep ^a   Murphy, Caragh S ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Chemotherapy; Implant; Polymeric systems; Solid tumors; Stimuli responsive

Indexed keywords

ALBUMIN; ALGINIC ACID; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARMUSTINE; CHITOSAN DERIVATIVE; CISPLATIN; COLLAGEN; CREMOPHOR; DOXORUBICIN; EPHEDRINE; FLUOROURACIL; GOSERELIN; INTERLEUKIN 2; LEUPRORELIN; MACROGOL; METHOTREXATE; MITOXANTRONE; ONCOGEL; PACLITAXEL; PLACEBO; POLOXAMER; POLY(N ISOPROPYLACRYLAMIDE); POLYANHYDRIDE; POLYCAPROLACTONE; POLYGLYCOLIC ACID; POLYMER; SILICONE; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VACCINE;

BIODEGRADABLE IMPLANT; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RESISTANCE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; GLIOBLASTOMA; HEAD AND NECK TUMOR; HUMAN; IMPLANT; LIVER CELL CARCINOMA; LOADING DRUG DOSE; MEDICAL RESEARCH; NONHUMAN; OVARY CANCER; PROSTATE CANCER; REVIEW; SOLID TUMOR;

ABSORBABLE IMPLANTS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; POLYMERS;

EID: 80053090683     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2011.602671     Document Type: Review

References (107)

1. Murray JC, Carmichael J. Targeting solid tumours: challenges, disappointments, and opportunities. Adv Drug Deliv Rev 1995;17:117-27
2. Au JL, Jang SH, Zheng J, et al. Determinants of drug delivery and transport to solid tumors: Computational model of intracellular pharmacokinetics of paclitaxel. J Control Release 2001;74:31-46
3. Makrilia N, Lappa T, Xyla V, et al. The role of angiogenesis in solid tumours: An overview. Eur J Int Med 2009;20:663-71
4. Gaze MN, Wheldon TE, O'Donoghue JA, et al. Multi-modality megatherapy with [131I] metaiodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: Feasibility study of a new strategy for advanced neuroblastoma. Eur J Cancer 1995;31:252-6
5. Schiller G. 2008 High-dose consolidation chemotherapy V bone marrow transplantation as postremission therapy in adult acute myeloid leukemia medicine. Available from: http://www. meds.com/leukemia/trends/mon-pt2.html [Last accessed 6 May 2009]
6. Rottenberg S, Jonkers J. Modeling therapy resistance in genetically engineered mouse cancer models. Drug Resist Updat 2008;11:51-60
7. Ge P, Luo Y, Fu S, et al. Autophagy: A strategy for malignant gliomas' resistance to therapy. Med Hypotheses 2009;73:45-7
8. Hughes GA. Nanostructure-mediated drug delivery. Nanomedicine 2005;1(1):22-30 (Pubitemid 43963612)
9. Prabaharan M, Grailer JJ, Pilla S, et al. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(l-lactide and poly (ethylene glycol) for tumour-targeted drug delivery. Biomaterials 2009;30:3009-19
10. Packhaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 2004;58:445-55 (Pubitemid 39037247)
11. Vassileva V, Grant J, Souza R, et al. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model. Cancer Chemother Pharmacol 2007;60:907-14 (Pubitemid 47389398)
12. Pulsipher MA, Bader P, Klingebiel T, Cooper LJN. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: The emerging Role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse. Biol Blood Marrow Transplant 2009;15:62-71
13. Berrada M, Serreqi A, Dabbarh F, et al. A novel non-toxic camptothecin formulation for cancer chemotherapy. Biomaterials 2005;26:2115-20 (Pubitemid 39575354)
14. Jackson JK, Gleave ME, Yago V, et al. The suppression of human prostate tumor growth in mice by the intratumoral injection of a slow-release polymeric paste formulation of paclitaxel. Cancer Res 2000;60:4146-51 (Pubitemid 30636597)
15. Eliaz R, Kost J. Composition and method for forming biodegradable implants in situ and uses of these implants. US6206920; 2001
16. Brem H. 1996. Developmental therapeutics program. National Cancer Institute (USA). Available from: http://images.google.co.za/imgres?imgurl=http:/ /dtp.nci.nih.gov/timeline/images/subs/success-stories/SS-1/SS-1-Gliadel-72dpi- small.jpg&imgrefurl=http://dtp.nci.nih.gov/timeline/noflash/success-stories/ S1-Carmustine.htm [Last accessed 6 May 2009]
17. Gopferich A. Bioerodable implants with programmable release. J Control Release 1997;44:271-81
18. Pezron E, Leibler L, Ricard A, Audebert R. Reversible gel formation induced by ion complexation. 2. Phase diagrams. Macromolecules 1988;21:1126-31 (Pubitemid 18618885)
19. Bosch P, Del Monte F, Mateo JL, Levy D. Photopolymerization of hydroxyethylmethacrylate in the formation of organic-inorganic hybrid sol-gel matrices. J Polym Sci Polym Chem 2000;34:3289-96
20. Wei H, He J, Sun L, et al. Gel formation and photopolymerization during supramolecular self-assemblies of alpha-CDs with LA-PEG-LA copolymer end-capped with methacryloyl groups. Eur Polym J 2005;41:948-57 (Pubitemid 40305024)
21. Klouda L, Mikos AG. Review article: thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008;68:34-45 (Pubitemid 350181413)
22. Puccetti G, Leblanc RM. Direct Evidence of the liquid-solid transition of a Sol-Gel material using photoacoustic spectroscopy. J Phys Chem 1996;100:1731-7 (Pubitemid 126789989)
23. Park KH, Song SC. Morphology of spheroidal hepatocytes within injectable, biodegradable and thermo-sensitive poly (organophosphazene) hydrogel as cell delivery vehicle. J Biosci Bioeng 2006;101:238-42 (Pubitemid 44376741)
24. Zhang J, Misra RDK. Magnetic drug-targeting carrier encapsulated with thermo-sensitive smart polymer: core-shell nanoparticle carrier and drug release response. Acta Biomater 2007;3:838-50 (Pubitemid 47382675)
25. Lue SJ, Hsu J, Wei T. Drug permeation modeling through the thermo-sensitive membranes of poly(N-isopropylacrylamide) brushes grafted onto micro-porous films. J Membr Sci 2008;321(2):146-54
26. Cole MA, Voelcker NH, Thissen H, Griesser HJ. Stimuli-responsive interfaces and systems for the control of protein-surface and cell-surface interactions. Biomaterials 2009;30:1827-50
27. Babich A. Tumor necrosis by controlled ebullism. Med Hypotheses 2005;64:318-19 (Pubitemid 40022672)
28. He C, Kim SW, Lee DS. In situ gelling stimuli-sensitive block copolymer hydrogels for drug delivery. J Control Release 2008;127:189-207
29. Brinke GT, Karasz FE. Lower critical solution temperature behavior in polymer blends: compressibility and directional-specific interactions. Macromolecules 1984;17:815-20
30. Geever LM, Devine DM, Nugent MJD, et al. Lower critical solution temperature control and swelling behavior of physically crosslinked thermosensitive copolymers based on N-isopropylacrylamide. Eur Polym J 2006;42:2540-8 (Pubitemid 44436155)
31. Zhou Y, Yan D, Dong W, Tian Y. Temperature-responsive phase transition of polymer vesicles: real-time morphology observation and molecular mechanism. J Phys Chem B 2007;111:1262-70 (Pubitemid 46339051)
32. Hacker MC, Klouda L, Ma BB, et al. Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N- isopropylacrylamide)-based macromers. Biomacromolecules 2008;9:1558-70 (Pubitemid 351954429)
33. Schuetz YB, Gurny R, Jordan O. A novel thermoresponsive hydrogel based on chitosan. Eur J Pharm Biopharm 2008;68:19-25 (Pubitemid 350181419)
34. Martin G, Jain RK. Non-invasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res 1994;54:5670-4 (Pubitemid 24346265)
35. Schmaljohann D. Thermo-and pH-responsive polymers in drug delivery. Adv Drug Deliv Rev 2006;58:1655-70 (Pubitemid 44830149)
36. Ravivarapu HB, Moyer KL, Dunn RL. Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant. AAPS PharmSciTech 2000;1(1):article 1
37. Meyer DE, Shin BC, Kong GA, et al. Drug targeting using thermally responsive polymers and local hyperthermia. J Control Release 2001;74:213-24 (Pubitemid 32727623)
38. Ho EA, Vassileva V, Allen C, Piquette-Miller M. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. J Control Release 2005;104:181-91 (Pubitemid 40615245)
39. Obara K, Ishihara M, Ozeki Y, et al. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice. J Control Release 2005;110:79-89 (Pubitemid 41713933)
40. Li XY, Kong XY, Wang XH, et al. Gel-Sol-Gel thermo-gelation behavior study of chitosan-inorganic phosphate solutions. Eur J Pharm Biopharm 2010;75:388-92
41. Ono K, Saito Y, Yura H, et al. Photocrosslinkable chitosan as a biological adhesive. J Biomed Mater Res 2000;49:289-95
42. Ganguly S, Dash AK. A novel in situ gel for sustained drug delivery and targeting. Int J Pharm 2004;276:83-92 (Pubitemid 38542991)
43. Cho YI, Park S, Jeong SY, Yoo HS. In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates. Eur J Pharm Biopharm 2009;73:59-65
44. Soo PL, Cho J, Grant J, et al. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: effect of swelling, degradation and morphology. Eur J Pharm Biopharm 2008;69:149-57
45. Ho EA, Soo PL, Allen C, Piquette-Miller M. Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors. J Control Release 2007;117:20-7 (Pubitemid 46161865)
46. Van Tomme SR, Storm G, Hennink WE. In situ gelling hydrogels for pharmaceutical and biomedical applications. Int J Pharm 2008;355:1-18
47. Hori Y, Winans AM, Irvine DJ. Modular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors. Acta Biomater 2009;5:969-82
48. Hatefi A and Amsden B. Biodegradable injectable in situ forming drug delivery systems. J Control Release 2002;80:9-28 (Pubitemid 34273745)
49. Bouhadir K, Alsberg E, Mooney DJ. Hydrogels for combination delivery of antineoplastic agents. Biomaterials 2001;22:2625-33 (Pubitemid 32727837)
50. Jeyanthi R, Rao KP. Controlled release of anticancer drugs from collagen-poly (HEMA) hydrogel matrices. J Control Release 1990;13:91-8 (Pubitemid 20221205)
51. Van Den Bulcke AI, Bogdanov B, De Rooze N. Structural and rheological properties of methacrylamide modified gelatin hydrogels. Biomacromolecules 2000;1:31-8
52. Gupta P, Vermani K, Garg S. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discov Today 2002;7:569-80
53. Okino H, Nakayama Y, Tanaka M, Matsuda T. In situ hydrogelation of photocurable gelatin and drug release. J Biomed Mater Res 2002;59:233-45
54. Liu L, Sakaguchi T, Kanda T, et al. Delivery of interleukin-12 in gelatin hydrogels effectively suppresses development of transplanted colonal carcinoma in mice. Cancer Chemother Pharmacol 2003;51:53-7 (Pubitemid 36057023)
55. Kang HW, Tabata Y, Ikada Y. Fabrication of porous gelatin scaffolds for tissue engineering. Biomaterials 1999;20:1339-44 (Pubitemid 29281386)
56. Hong L, Tabata Y, Miyamoto S, et al. Bone regeneration at rabbit skull defects treated with transforming growth factor-b1 incorporated into hydrogels with different levels of biodegradability. J Neurosurg 2000;92:315
57. Konishi M, Tabata Y, Kariya M, et al. In vivo anti-tumor effect of dual release of cisplatin and adriamycin from biodegradable gelatin hydrogel. J Control Release 2005;103:7-19 (Pubitemid 40248557)
58. Kakinoki S, Taguchi T, Saito H, et al. Injectable in situ forming drug delivery system for cancer chemotherapy using a novel tissue adhesive: characterization and in vitro evaluation. Eur J Pharm Biopharm 2007;66:383-90 (Pubitemid 46756224)
59. Kakinoki S, Taguchi T. Antitumor effect of an injectable in-situ forming drug delivery system composed of a novel tissue adhesive containing doxorubicin hydrochloride. Eur J Pharm Biopharm 2007;67:676-81 (Pubitemid 47576606)
60. Mok TS, Kanekal S, Lin XR, et al. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma. Cancer Chemother Pharmacol 2001;91:2369-77 (Pubitemid 32552824)
61. Wenig BL, Werner JA, Castro DJ, et al. The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2002;128:880-5 (Pubitemid 34856255)
62. Burris HA III, Vogel CL, Castro D, et al. Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg 1998;118:496-503 (Pubitemid 28177981)
63. Smith J, Stock E, Orenberg EK, et al. Intratumoral chemotherapy with sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts. Anticancer Drugs 1995;6:717-26 (Pubitemid 26018615)
64. Han J, Wang K, Yang D, Nie J. Photopolymerization of methacrylated chitosan/PNIPAAm hybrid dual-sensitive hydrogels as carrier for drug delivery. Int J Biol Macromol 2009;44:229-35
65. Winnik FM. Phase transitions of poly-(N-isopropylacrylamide) solutions: A study by non-radiative energy transfer. Polymer (Guildf) 1990;31:2125-34
66. Jones DS, McMeel S, Adair CG, Gorman SP. Characterisation and evaluation of novel surfactant bacterial anti-adherent coatings for endotracheal tubes designed for the prevention of ventilator-associated pneumonia. J Pharm Pharmacol 2003;55:43-52 (Pubitemid 36142080)
67. Yu Y, Li Z, Tian H, et al. Synthesis and characterization of thermoresponsive hydrogels cross-linked with acryloyloxyethylaminopolysuccinimide. Colloid Polym Sci 2007;285:1553-60 (Pubitemid 350066297)
68. Kim S, Healy KE. Synthesis and characterization of injectable Poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules 2003;4:1214-23 (Pubitemid 37184633)
69. Zhang X, Du D, Chu CC. Synthesis and characterization of partially biodegradable, temperature and pH sensitive Dex-MA/PNIPAAm hydrogels. Biomaterials 2004;25:4719-30 (Pubitemid 38561159)
70. Hiremath JG, Devi VK, Devi K, Domb AJ. Biodegradable poly(sebacic acid-co-ricinoleic-ester anhydride) tamoxifen citrate implants: preparation and in vitro characterization. J Appl Polym Sci 2008;107:2745-54 (Pubitemid 351238701)
71. Jeong B, Bae YH, Kima SW. Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. J Control Release 2004;63:155-63
72. Chen S, Singh J. Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation. Int J Pharm 2005;295:183-90 (Pubitemid 40558801)
73. Astaneh R, Nafissi-Varcheh N, Erfan M. Zinc-leuprolide complex: preparation, physicochemical characterization and release behavior from in situ forming implant. J Pept Sci 2007;13:649-54 (Pubitemid 47570383)
74. Chen F, Kuriakose MA, Zhou M, et al. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model. Head Neck 2003;25:7554-60
75. Al-Abd AM, Hong K-Y, Song S-C, Kuh H-J. Pharmacokinetics of doxorubicin after intratumoral injection using a thermosensitive hydrogel in tumor-bearing mice. J Control Release 2010;142:101-7
76. Sharifi S, Mirzadeh H, Imani M, et al. Injectable in situ forming drug delivery system based on poly(epsilon-caprolactone fumarate) for tamoxifen citrate delivery: Gelation characteristics, in vitro drug release and anti-cancer evaluation. Acta Biomater 2009;5:1966-78
77. Qiu B, Stefanos S, Ma J, et al. A hydrogel prepared by in situ cross-linking of a thiol-containing poly (ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. Biomaterials 2003;24:11-18 (Pubitemid 35300198)
78. Lalloo A, Chao P, Hu P, et al. Pharmacokinetic and pharmacodynamic evaluation of a novel in situ forming poly(ethylene glycol)-based hydrogel for the controlled delivery of the camptothecins. J Control Release 2006;112:333-42 (Pubitemid 43737145)
79. Tauro JR, Gemeinhart RA. Matrix Metalloprotease Triggered Delivery of Cancer Chemotherapeutics from Hydrogel Matrixes. Bioconjug Chem 2005;16:1133-9 (Pubitemid 41368115)
80. Lee LY, Ranganath SH, Fu Y, et al. Paclitaxel release from micro-porous PLGA discs. Chem Eng Sci 2009;64:4341-9
81. Ranganath SH, Fu Y, Arifin DY, et al. The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma mice. Biomaterials 2010;31:5199-207
82. Brem H, Piantadosi S, Burger PC, et al. Placebo controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995;345:1008-12
83. Perry J, Chambers A, Spithoff K, Laperriere N. Gliadel wafers in the treatment of malignant glioma: a systematic review. Curr Oncol 2007;14:189-94
84. Chopko BW. Intracavitary carmustine polymer implantation as an adjunct to palliative metastatic vertebral column tumors. Surg Neurol 2009;72:553
85. Argyriou AA, Antonacopoulou A, Iconomou G, Kalofonos HP. Treatment options for malignant gliomas, emphasizing towards new molecularly targeted therapies. Crit Rev Oncol Hematol 2009;69:99-210
86. Jain JP, Modi S, Domb AJ, Kumar N. Role of polyanhydrides as localized drug carriers. J Control Release 2005;103:541-63 (Pubitemid 40476140)
87. Gopferich A. Bioerodable implants with programmable release. J Control Release 1997;44:271-81
88. Vogelhuber W, Rotunno P, Magni E, et al. Programmable biodegradable implants. J Control Release 2001;73:75-88 (Pubitemid 32406103)
89. Madan M, Bajaj A, Lewis S, et al. In situ forming polymeric drug delivery systems. Indian J Pharm Sci 2009;71:242-51
90. Yu L, Chang GT, Zhang H, Ding JD. Injectable block copolymer hydrogels for sustained release of a PEGylated drug. Int J Pharm 2007;348:95-106
91. Exner AA, Krupka TM, Scherrer K, Teets JM. Enhancement of carboplatin toxicity by Pluronic block copolymers. J Control Release 2005;106:188-97 (Pubitemid 41140094)
92. Amiji MM, Lai PK, Shenoy DB, Rao M. Intratumoral administration of paclitaxel in an in situ gelling poloxamer 407 formulation. Pharm Dev Technol 2007;7:195-202 (Pubitemid 34595000)
93. Bae WK, Lee JH, Lee SJ, et al. Enhanced anti-cancer effect of 5-Fluorouracil loaded into thermo-responsive conjugated linoleic acid-incorporated poloxamer hydrogel on metastatic colon cancer models. J Nanosci Nanotechnol 2011;11:1425-8
94. Ta HT, Dass CR, Dunstan DE. Injectable chitosan hydrogels for localized cancer therapy. J Control Release 2008;126:205-16
95. Gong CY, Shi S, Wu L, et al. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel, Part 2: sol-gel-sol transition and drug delivery behavior. Acta Biomater 2009;5:3258-70
96. Fang F, Gong CY, Qian ZY, et al. Honokiol nanoparticles in thermosensitive hydrogel: therapeutic effects on malignant pleural effusion. ACS Nano 2009;3:4080-8
97. He YC, Chen JW, Cao J, et al. Toxicities and therapeutic effect of fluorouracil controlled release implant on tumor bearing rats. World J Gastroenterol 2003;9:1795-9
98. Winternitz CI, Jackson JK, Oktaba AM, Burt HM. Development of a polymeric surgical paste formulation for taxol. Pharm Res 1996;13:368-75 (Pubitemid 26114726)
99. Jackson JK, Zhang X, Llewellen S, et al. The characterization of novel polymeric paste formulations for intratumoral delivery. Int J Pharm 2004;270:185-98 (Pubitemid 38077099)
100. Dordunoo SK, Oktaba AMC, Hunter W, et al. Release of taxol from poly(epsi-caprolactone) pastes: effect of water-soluble additives. J Control Release 1997;44:87-94 (Pubitemid 27051337)
101. Hunter WL, Burt HM, Machan L. Local delivery of chemotherapy: a supplement to existing cancer treatments: a case for surgical pastes and coated stents. Adv Drug Deliv Rev 1997;26:199-207 (Pubitemid 27289534)
102. Dijkman GA, del Moral PF, Plasman JWMH, et al. A new extra long acting depot preparation of the LHRH analogue Zoladex®: first endocrinological and pharmacokinetic data in patients with advanced prostate cancer. J Steroid Biochem Mol Biol 1990;37:933-6
103. Chertin B, Spitz IM, Lindenberg T, et al. An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer. J Urol 2004;163:838-44 (Pubitemid 30091628)
104. Ruel-Gariepy E, Shive M, Bichara A, et al. A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel. Eur J Pharm Biopharm 2004;57:53-63 (Pubitemid 38058803)
105. Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 1999;20:2169-75 (Pubitemid 29488666)
106. Packhauser CB, Schneiders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm 2004;58:445-5
107. Chenite A, Chaput C, Wang D, et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000;21:2155-61 (Pubitemid 30612386)